Partnerships
AiRISTA Adds BD Alaris Infusion Data to Sofia in New Software Integration
By News Desk ·
Key takeaways
- AiRISTA announced an official software integration that brings BD Alaris Infusion System data into its Sofia platform.
- AiRISTA Chief Commercial Officer Wyatt Meek said the integration reinforces AiRISTA's role as a central intelligence layer for healthcare operations.
- BD Vice President and General Manager for Infusion Solutions Ken Gelhaus said the collaboration strengthens BD's connected infusion ecosystem.
- AiRISTA released a new version of Sofia in July 2026 with Single Sign-On, Multi-Factor Authentication and TLS 1.3.
AiRISTA announced an official software integration with BD on November 17, 2026, enabling data from the BD Alaris Infusion System to flow into AiRISTA's Sofia platform. The integration is designed to support infusion operations and clinical workflows without new infrastructure, PR Newswire reported.
How the AiRISTA and BD Integration Works
The integration makes key data from the BD Alaris Infusion System available within AiRISTA's Sofia platform, which the company describes as a unified platform for contextualizing infusion information alongside other operational and workflow data. AiRISTA said hospitals can align infusion workflows with other operational insights without introducing new infrastructure or disrupting existing systems. The company said the integration supports equipment readiness, therapy continuity and clinical responsiveness.
"This integration with the BD Alaris™ Infusion System reinforces AiRISTA's role as a central intelligence layer for healthcare operations," said Wyatt Meek, Chief Commercial Officer at AiRISTA. "By enabling infusion-related information to flow into Sofia, we're helping health systems break down data silos and turn disparate system data into actionable insight that supports clinicians, biomedical teams, and operational leaders alike."
BD reported fourth quarter fiscal 2026 revenue of $5.3 billion, up 5.4% as reported, and full-year revenue of $19.5 billion, up 4.9%, according to PR Newswire. Ken Gelhaus, Vice President and General Manager for Infusion Solutions at BD, said: "This collaboration with AiRISTA strengthens our connected infusion ecosystem by providing greater visibility into infusion status, enabling healthcare teams to deploy equipment more intelligently and support the timely delivery of critical therapies."
AiRISTA's Earlier RTLS Partnerships
According to akta.pro company records, AiRISTA was named a founding vendor of the RTLS Alliance Ecosystem in December 2025 alongside LocaXion and Slamcore, an effort aimed at standardization and interoperability of RTLS technologies across healthcare, manufacturing and logistics. The same records list HPE Aruba and Juniper Networks as technology partners within AiRISTA's ecosystem, providing networking infrastructure and solutions that integrate with its RTLS platform.
Sofia Releases and Recognition Before the BD Deal
AiRISTA announced a new version of its Sofia real-time location intelligence platform in July 2026, featuring enterprise-grade security enhancements including Single Sign-On, Multi-Factor Authentication and TLS 1.3, along with a centralized Integrations Hub supporting leading wireless infrastructure and enterprise applications, PR Newswire reported. That same month, Frost & Sullivan awarded AiRISTA its 2026 North American Competitive Strategy Leadership Recognition in the healthcare asset management solutions industry, recognizing the company's achievements in competitive strategy, innovation and customer impact, according to PR Newswire APAC.
What the BD Collaboration Sets Up Next
AiRISTA said the official integration establishes a foundation for future collaboration between the two companies, enabling healthcare systems to continue evolving their digital ecosystems over time. Meek added: "This partnership demonstrates what's possible when healthcare technology leaders focus on interoperability and real-world workflows."